Study challenges link between infant cardiac defects and maternal antidepressants

06/30/2014 | CardiovascularBusiness.com

Contrary to other reports, a new study in the New England Journal of Medicine found little evidence of a link between cardiac birth defects and antidepressant use among pregnant women. Among other findings, the study showed no significant link between right ventricular outflow tract obstruction and the antidepressant paroxetine or ventricular septal defect and sertraline. One possible factor in such studies is that women with anxiety or depression may be more likely to be closely monitored with ultrasonography and other tests, leading to findings that might otherwise go undetected in women not watched as carefully.

View Full Article in:

CardiovascularBusiness.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY